In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018


May 8, 2012
176 Pages - SKU: GBDT3890470
License type:
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
5/8/2013 | published by: Kalorama Information
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis,  |  read more...
$4,500.00
AbaStar MDx, Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary AbaStar MDx, Inc. (AbaStar) is a physiological diagnostics provider. It develops blood-based gene expression and molecular diagnostic tests for the diagnosis of mental disorders and neurodegenerative diseases. The company provides physiological diagnostics from the molecular  |  read more...
$750.00
Alfa Wassermann, Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Alfa Wassermann, Inc. (Alfa Wassermann) is a clinical device manufacturer. It designs and manufactures devices and equipment for clinical laboratories and diagnostic centers. The company’s products include medical diagnostic instruments and reagents such as Alera  |  read more...
$750.00
Autoimmune Technologies, LLC - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Autoimmune Technologies, LLC (Autoimmune) is a biomedical company. The company develops medical diagnostic tests, explores disease mechanisms and investigates therapies for autoimmune diseases and disorders. It develops anti-viral drugs that are designed to prevent viral  |  read more...
$750.00
Biomagnetics Diagnostics Corporation (BMGP) - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Biomagnetics Diagnostics Corporation (Biomagnetics Diagnostics) is a medical devices and biotechnology company. The company designs, patents and markets diagnostic equipment and immunoassays, and other biotechnologies. Its products include high throughput screening - magnetic testing platform  |  read more...
$750.00
BioTex, Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary BioTex, Inc. (BioTex) is a medical technology company. It explores, develops and commercializes novel optical technologies for medical, biomedical, and environmental applications. It develops technologies for both diagnostic and therapeutic medical applications. It undertakes the  |  read more...
$750.00
Focus Diagnostics, Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Focus Diagnostics, Inc. (Focus Diagnostics) is a medical device company. The company manufactures and distributes molecular and immunology products. Its products include 3M integrated cycler, simplexa molecular products, herpeselect type, dxselect serology products, serology reagents  |  read more...
$750.00
Great Basin Corporation - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Great Basin Corporation (Great Basin) is a life science company. The company develops and distributes point-of-care technology and products which improve automation, throughput, scalability, reliability and ease-of-use in rapid diagnostic testing. It develops tests in  |  read more...
$750.00
Luminex Corporation (LMNX) - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Luminex Corporation (Luminex) is a medical devices company, which develops, manufactures and markets its proprietary biological testing technologies. Its proprietary technologies consist of xMAP technology, xTAG and MultiCode technology. It operates its business through two  |  read more...
$750.00
Mitomics Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Mitomics Inc. (Mitomics) is a medical diagnostic device manufacturing company. The company researches and develops mitochondrial genome-based products to improve clinical insight and therapeutic decisions. It develops mitochondria DNA based biomarkers for the screening, diagnosis  |  read more...
$750.00